To access the full text documents, please follow this link: http://hdl.handle.net/2445/118847
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Ettcheto, Miren |
dc.contributor.author | Sánchez-López, E. (Elena) |
dc.contributor.author | Pons, Laura |
dc.contributor.author | Busquets Figueras, Oriol |
dc.contributor.author | Olloquequi González, Jordi |
dc.contributor.author | Beas Zárate, Carlos |
dc.contributor.author | Pallàs i Llibería, Mercè, 1964- |
dc.contributor.author | García López, María Luisa |
dc.contributor.author | Auladell i Costa, M. Carme |
dc.contributor.author | Folch, Jaume |
dc.contributor.author | Camins Espuny, Antoni |
dc.date | 2017-12-21T14:20:21Z |
dc.date | 2017-12-21T14:20:21Z |
dc.date | 2017-06-15 |
dc.date | 2017-12-21T14:20:21Z |
dc.identifier.citation | 2213-2317 |
dc.identifier.citation | 672735 |
dc.identifier.uri | http://hdl.handle.net/2445/118847 |
dc.format | 8 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier B.V. |
dc.relation | Reproducció del document publicat a: https://doi.org/10.1016/j.redox.2017.06.003 |
dc.relation | Redox Biology, 2017, vol. 13, p. 345 -352 |
dc.relation | https://doi.org/10.1016/j.redox.2017.06.003 |
dc.rights | cc-by-nc-nd (c) Elsevier B.V., 2017 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/es |
dc.subject | Malaltia d'Alzheimer |
dc.subject | Hipocamp (Cervell) |
dc.subject | Receptors d'insulina |
dc.subject | Mitocondris |
dc.subject | Medicaments |
dc.subject | Alzheimer's disease |
dc.subject | Hippocampus (Brain) |
dc.subject | Insulin receptors |
dc.subject | Mitochondria |
dc.subject | Drugs |
dc.title | Dexibuprofen prevents neurodegeneration and cognitive decline in APPswe/PS1dE9 through multiple signaling pathways. |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/acceptedVersion |
dc.description.abstract |